Dr. Sashidhar Seshukumar Movva, MD

Dr. Movva practices at University Physical Therapy Associates - Largo in Largo, Maryland.

Dr. Movva's NPI, 1265486252, was assigned on May 22, 2006. Dr. Movva holds Maryland license D39600.

Dr. Movva's primary practice is University Physical Therapy Associates - Largo, at 1100 Mercantile Lane, Suite 150, Largo, MD 20774. The practice phone is (301) 322-9495.

Dr. Movva's primary practice is University Physical Therapy Associates - Largo in Largo, Maryland. The medical group on file is MedStar Shah Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Movva practices. Vendor and product names are available with a free account.

Neuromusculoskeletal medicine and omm is Dr. Movva's primary specialty in the NPI Registry, under taxonomy code 204D00000X. Dr. Movva is licensed in Maryland.

CMS data shows 963 Medicare services from Dr. Movva across 8 procedure codes in 2024, for 278 Medicare patients. Medicare paid $115,561 for them. Every service was in an office.

CMS counts 278 Medicare patients who saw Dr. Movva in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Movva's median patient age at 69, with 56% women.

In 2024, Dr. Movva wrote 745 Medicare Part D claims for 157 patients. 88% of them were for generic drugs. CMS names the drug for 574 of them, across 19 drugs with 11 or more claims each, at $229,792 in total drug cost. In 2023, CMS named 609 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Movva for performance year 2024, reported individually. Dr. Movva accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Movva as offering telehealth.

CMS Open Payments shows 328 general payments to Dr. Movva from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $943.